Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Pigment Cell & Melanoma Research|May 15, 2020
RAC1mutation is not a predictive biomarker for PI3'-kinase-β-selective pathway-targeted therapyMona Foth, Gennie Parkman, Benjamin Battistone, et al.Surgical Oncology Clinics of North America|September 13, 2021
Therapeutic Targeting of Autophagy in Pancreatic CancerMona Foth, Ignacio Garrido-Laguna, Conan G KinseyExpert Review of Molecular Diagnostics|December 2, 2015
Prognostic and predictive biomarkers in melanoma: an updateMona Foth, Jasper Wouters, Ciaran de Chaumont, et al.Experimental Dermatology|October 30, 2021
The role of PI3'-lipid signalling in melanoma initiation, progression and maintenanceGennie L Parkman, Mona Foth, David A Kircher, et al.Disease Models & Mechanisms|April 21, 2011
K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladderImran Ahmad, Lukram Babloo Singh, Mona Foth, et al.The Journal of Pathology|July 26, 2018
FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammationMona Foth, Nur Faezah Binti Ismail, Jeng Sum Charmaine Kung, et al.Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Loss of Cxcr2 in Myeloid Cells Promotes Tumour Progression and T Cell Infiltration in Invasive Bladder CancerNur Faezah Binti Ismail, Mona Foth, Amal Rahil Elgaddafi Yousef, et al.The Journal of Pathology|February 13, 2014
Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation with Pten loss in miceMona Foth, Imran Ahmad, Bas W G van Rhijn, et al.The Journal of Pathology|May 8, 2015
CXCR2 inhibition suppresses acute and chronic pancreatic inflammationColin W Steele, Saadia A Karim, Mona Foth, et al.Pageof 2